MINAMINO COMPOUND​ SYRUP

Indications

• General wellness support
• Anti-inflammatory effects
• Antioxidant activity
• Digestive aid
• Support for immune function

Dosage

Children: Paediatric dosing should be determined based on the specific extract and its intended use. Consultation with a healthcare provider is recommended for accurate dosing.

Adults: Dosage varies widely depending on the specific extract and formulation. It is essential to follow the manufacturer's instructions or consult a healthcare professional for appropriate dosing.

Mechanism of action

The mechanism of action of herbal extracts can vary significantly based on their constituents. Commonly, they exert their effects through multiple pathways including modulation of neurotransmitter systems, interference with inflammatory processes, or direct antioxidant activity. Some extracts may activate certain receptors or inhibit enzymes related to disease processes.

Pharmacodynamics

The pharmacodynamics of extracts is complex due to the presence of multiple active compounds which can have synergistic or antagonistic effects. These compounds may influence cellular signaling pathways, alter gene expression, or modulate immune response. The overall pharmacological profile is determined by the specific composition of the extract, its concentration, and the biological target it interacts with.

Pharmacokinetics

The pharmacokinetics of extracts involves absorption, distribution, metabolism, and excretion of the active compounds. Generally, herbal extracts are absorbed in the gastrointestinal tract, with bioavailability influenced by factors such as formulation, the presence of food, and individual metabolic differences. Compounds may undergo hepatic metabolism, and elimination can occur through urine or feces, depending on their chemical nature.

Pregnancy

Consult a healthcare professional before use, as the safety of the extract during pregnancy has not been established.

Breast-feeding

Consult a healthcare professional before use, as the safety of the extract during breastfeeding has not been established.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Gastroesophageal reflux disease (GERD)
• Peptic ulcer disease
• Dyspepsia
• Zollinger-Ellison syndrome
• Esophagitis
• Stress ulcer prophylaxis

Dosage

Children: Dosing varies by specific medication and

Adults: Dosing varies by specific medication and condition. Refer to the relevant prescribing information for exact dosing.

Mechanism of action

Proton pump inhibitors, for example, work by irreversibly inhibiting the H+/K+ ATPase enzyme system at the surface of the gastric parietal cells, leading to a profound and long-lasting reduction in gastric acid secretion. H2-receptor antagonists block the action of histamine on the H2 receptors of parietal cells, decreasing acid production. Antacids neutralize stomach acid through a chemical reaction, providing symptomatic relief.

Pharmacodynamics

The pharmacodynamics of gastric medications vary by class. Proton pump inhibitors have a long duration of action and provide a significant decrease in gastric acid secretion, resulting in increased gastric pH. H2-receptor antagonists provide shorter-term reductions in acid secretion, while antacids offer immediate relief by neutralizing existing gastric acid. The effectiveness of these drugs can be influenced by factors such as gastric emptying and the presence of food in the stomach.

Pharmacokinetics

Pharmacokinetics can vary widely among different gastric medications. Proton pump inhibitors are typically administered as prodrugs and are activated in the acidic environment of the parietal cell canaliculus. They are well absorbed from the gastrointestinal tract and have a half-life of one to two hours, but their effects can last up to 24 hours. H2-receptor antagonists are absorbed in the small intestine and have a half-life of approximately one to three hours, while antacids have a rapid onset of action but a short duration of effect, often requiring multiple doses throughout the day.

Pregnancy

Consult a healthcare provider for guidance on use during pregnancy. Safety data may vary depending on specific gastric medications.

Breast-feeding

Consult a healthcare provider for guidance on use during breastfeeding. Safety data may vary depending on specific gastric medications.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Indications

• Liver function tests
• Hepatic encephalopathy
• Liver cirrhosis
• Hepatitis
• Fatty liver disease
• Drug metabolism monitoring

Dosage

Children: Dosing for pediatric patients should always be referenced from established guidelines or the BNF for Children, as it varies significantly based on age, weight, and specific liver-related conditions.

Adults: Dosing for liver-related therapies depends on the specific condition and drug being utilized. Refer to specific drug monographs for detailed dosing information.

Mechanism of action

The liver functions through various pathways, including the hepatic portal system, where nutrients absorbed from the gastrointestinal tract are transported to the liver for processing. Hepatocytes, the functional cells of the liver, engage in metabolic processes such as gluconeogenesis, glycogenolysis, and lipid synthesis. The liver also produces proteins such as albumin and clotting factors, and detoxifies drugs and metabolites through enzymatic reactions involving cytochrome P450 enzymes.

Pharmacodynamics

Pharmacodynamics in relation to liver function often involves the liver's capacity to metabolize drugs and regulate their pharmacological effects. It affects the bioavailability of drugs, their half-life, and overall efficacy. Hepatic dysfunction can lead to altered drug metabolism, resulting in increased drug accumulation and potential toxicity.

Pharmacokinetics

Pharmacokinetics related to liver function involves the absorption, distribution, metabolism, and excretion (ADME) of substances. After oral administration, drugs are absorbed in the gastrointestinal tract and transported via the portal vein to the liver. The liver metabolizes drugs through phase I (oxidation, reduction, hydrolysis) and phase II (conjugation) reactions. Metabolites are then excreted into bile or transported to the kidneys for renal excretion. Factors such as hepatic blood flow, enzyme activity, and liver disease can significantly impact these processes.

Pregnancy

Liver function is crucial during pregnancy, and any liver disease can significantly impact both maternal and fetal health. Careful monitoring and management of liver function are essential.

Breast-feeding

Liver health is important during breastfeeding, as liver function affects the metabolism and clearance of drugs that may be excreted in breast milk.

Storage

Liver tissue should be handled and stored in accordance with laboratory guidelines, ensuring it is preserved properly for analysis or transplantation.

Indications

• Cough associated with colds
• Bronchitis
• Respiratory infections
• Conditions with excessive mucus production

Dosage

Children: For children aged 6 to 12 years, the recommended dosage is 100 to 200 mg orally every 4 hours, not to exceed 1200 mg per day. For children aged 2 to 6 years, consult specific

Adults: The usual adult dosage is 200 to 400 mg orally every 4 hours, as needed. The maximum daily dose should not exceed 2400 mg.

Mechanism of action

Guaifenesin is believed to function by increasing mucus secretion and acting as an irritant to gastric vagal receptors. This recruitment of efferent parasympathetic reflexes leads to glandular exocytosis that produces a less viscous mucus mixture. Consequently, this promotes coughing that helps clear obstructed airways, improving respiratory function. Additionally, guaifenesin may exhibit anticonvulsant and muscle relaxant effects, possibly through NMDA receptor antagonism.

Pharmacodynamics

Guaifenesin is classified as an expectorant, enhancing the output of phlegm and bronchial secretions by decreasing their adhesiveness and surface tension. It promotes an increased flow of less viscous gastric secretions, which aids in ciliary action, converting dry, unproductive coughs into more productive ones. This process enhances mucociliary activity, facilitating the removal of secretions from both the upper and lower airways.

Pharmacokinetics

Guaifenesin is absorbed from the gastrointestinal tract and is rapidly distributed throughout the body. It is metabolized primarily in the liver and excreted in the urine. The onset of action typically occurs within 30 minutes to 1 hour, with effects lasting for several hours, depending on dosage and individual metabolism. The elimination half-life is approximately 1 hour.

Adverse effects

• Nausea
• Vomiting
• Dizziness
• Headache
• Rash

Precautions

• Caution in patients with asthma or chronic bronchitis as increased mucus production may exacerbate symptoms.
• Use with caution in patients with a history of hypersensitivity to guaifenesin or any of its components.

Pregnancy

Guaifenesin should only be used in pregnancy if the potential benefit justifies the potential risk to the fetus. Consult healthcare professionals for guidance.

Breast-feeding

It is not known whether guaifenesin is excreted in human breast milk. Caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place at room temperature, away from light. Keep out of reach of children.

Formulations

• Oral tablets
• Oral syrup
• Oral granules

Indications

• Nutritional supplementation
• Muscle repair and growth
• Immune support
• Enzyme replacement therapy
• Hormonal regulation

Dosage

Children: Refer to specific product guidelines for dosing information, as protein requirements in children vary based on age, growth stage, and health status.

Adults: Refer to specific product guidelines for dosing information, as protein requirements can vary widely based on individual needs, activity levels, and clinical conditions.

Mechanism of action

Proteins exert their effects primarily through their structure and interactions with other molecules. They can function as enzymes, hormones, and antibodies, and their action is often mediated by binding to specific receptors or substrates, leading to a change in cellular activity or function. For example, enzymes catalyze biochemical reactions, while antibodies bind to antigens to facilitate immune responses.

Pharmacodynamics

The pharmacodynamics of proteins can vary significantly depending on the specific protein being considered. Generally, the effects of proteins are dose-dependent and influenced by their concentration, affinity for targets, and duration of action. Proteins can have a wide range of biological activities, including promoting cellular repair, regulating metabolism, and modulating immune responses.

Pharmacokinetics

The pharmacokinetics of proteins includes their absorption, distribution, metabolism, and excretion (ADME). Proteins are typically digested in the gastrointestinal tract into amino acids before being absorbed into the bloodstream. Once in circulation, proteins can be distributed throughout various tissues. They may have a variable half-life based on their structure and function, and they are primarily metabolized by the liver and excreted via the kidneys. The pharmacokinetic profile can be influenced by factors such as the route of administration and the presence of other substances.

Pregnancy

Generally considered safe, but high protein intake should be monitored to avoid potential risks.

Breast-feeding

Adequate protein intake is critical for lactating women to support milk production and quality.

Storage

Store in a cool, dry place, away from direct sunlight.

Indications

• Administration of drugs requiring solubilization
• Intravenous fluid therapy
• Oral rehydration solutions

Dosage

Children: Refer to the BNF for Children for specific dosing information.

Adults: Refer to the BNF for specific dosing information.

Mechanism of action

The mechanism of action of soluble compounds typically involves their ability to dissociate in solution, allowing for increased bioavailability and enhanced pharmacological effects. In some cases, they may act as osmotic agents or facilitate the transport of drugs across biological membranes.

Pharmacodynamics

Pharmacodynamics of soluble compounds generally relates to their effects on the body, including their interaction with receptors, enzymes, or cellular pathways. The solubility enhances the distribution of the drug, leading to more predictable and effective therapeutic outcomes.

Pharmacokinetics

Pharmacokinetics involves the absorption, distribution, metabolism, and excretion of soluble compounds. Due to their solubility, these compounds are typically absorbed quickly into the bloodstream when administered orally or intravenously. They may undergo metabolism in the liver, and their elimination primarily occurs through renal pathways, depending on the specific compound and its formulation.

Indications

• Splenomegaly
• Hyposplenism
• Asplenia
• Splenic rupture
• Sickle cell disease
• Thalassemia
• Certain hematological disorders

Dosage

Children: Refer to clinical guidelines for specific conditions related to the spleen. No standard dosage exists as the spleen is an organ rather than a pharmacological agent.

Adults: Refer to clinical guidelines for specific conditions related to the spleen. No standard dosage exists as the spleen is an organ rather than a pharmacological agent.

Mechanism of action

The spleen functions primarily through its two main components: the white pulp and the red pulp. The white pulp contains lymphoid tissue, where lymphocytes are activated in response to pathogens. The red pulp is involved in filtering the blood, removing senescent red blood cells and debris. The spleen's immune responses include the production of antibodies and the activation of T-cells, allowing it to respond to infections effectively.

Pharmacodynamics

The spleen plays a critical role in both the innate and adaptive immune responses. It filters blood, removes foreign matter, and helps initiate immune responses by presenting antigens to lymphocytes. The organ also regulates the concentration of blood cells and platelets, maintaining homeostasis in the circulatory system. The dynamics of these functions can be influenced by various factors, including infection, stress, and overall health.

Pharmacokinetics

As an organ, the spleen does not have pharmacokinetic properties in the traditional sense associated with drugs. However, its function can be affected by systemic conditions, medications, and diseases that alter blood flow, immune function, or hematological status. Blood flow through the spleen is essential for its filtering and immune activities, with a typical blood volume of approximately 350 mL in adults at any given time.

Pregnancy

The spleen itself is an organ and does not have specific pregnancy-related considerations. However, conditions affecting the spleen may have implications in pregnancy.

Breast-feeding

Similar to pregnancy, the spleen does not directly impact breastfeeding. Any conditions affecting the spleen should be evaluated in the context of breastfeeding.

Storage

Not applicable, as the spleen is not a drug or substance that requires storage.

Indications

• Muscle building and recovery
• Supplementation for athletes
• Weight management
• Support for individuals with increased protein needs

Dosage

Children: Refer to product-specific recommendations and consult healthcare professionals for appropriate dosing in children.

Adults: Refer to product-specific recommendations, as dosages can vary widely based on individual goals and protein content.

Mechanism of action

Whey protein promotes muscle protein synthesis primarily through the activation of the mTOR (mechanistic target of rapamycin) pathway. This pathway plays a crucial role in cell growth and metabolism. The high leucine content in whey stimulates muscle protein synthesis more effectively than other protein sources. Additionally, whey protein can enhance the release of insulin, which further aids in amino acid uptake by muscle tissues.

Pharmacodynamics

Whey protein has been shown to increase muscle mass, strength, and recovery rates following exercise. Its rapid digestion and absorption make it ideal for post-workout nutrition, while its amino acid profile supports various physiological functions such as immune response and muscle repair. Whey has also been associated with benefits in weight management, as it can promote satiety and reduce appetite.

Pharmacokinetics

After ingestion, whey protein is rapidly digested and absorbed, leading to a quick increase in amino acid levels in the bloodstream. This rapid absorption supports immediate muscle recovery and growth post-exercise. The bioavailability of whey protein is high, with studies indicating that a significant portion of the ingested protein can be utilized by the body within a short timeframe. The half-life of specific amino acids can vary but typically ranges from a few hours to several hours depending on the specific amino acid and individual metabolism.

Adverse effects

• Allergic reactions in individuals with milk allergies
• Gastrointestinal discomfort or bloating
• Diarrhea in sensitive individuals

Precautions

• Use with caution in individuals with lactose intolerance
• Monitor for potential allergic reactions in individuals with a history of dairy allergies

Pregnancy

Whey protein is generally considered safe during pregnancy when consumed in moderation as part of a balanced diet. However, consult a healthcare provider before supplementing.

Breast-feeding

Whey protein is also considered safe during breastfeeding when consumed in moderation. Consultation with a healthcare provider is advised before use.

Storage

Store in a cool, dry place, away from direct sunlight. Ensure the container is tightly sealed.

Formulations

• Whey protein concentrate
• Whey protein isolate
• Hydrolyzed whey protein

Mechanism of action

Although the exact mechanism of action of guaifenesin may not yet be formally or totally elucidated, it is believed that expectorants like guaifenesin function by increasing mucus secretion. Moreover, it is also further proposed that such expectorants may also act as an irritant to gastric vagal receptors, and recruit efferent parasympathetic reflexes that can elicit glandular exocytosis that is comprised of a less viscous mucus mixture. Subsequently, these actions may provoke coughing that can ultimately flush difficult to access, congealed mucopurulent material from obstructed small airways to facilitate a temporary improvement for the individual. Consequently, while it is generally proposed that guaifenesin functions as an expectorant by helping to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive, there has also been research to suggest that guaifenesin possesses and is capable of demonstrating anticonvulsant and muscle relaxant effects to some degree possibly by acting as an NMDA receptor antagonist. Guaifenesin is thought to act as an expectorant by increasing the volume and reducing the viscosity of secretions in the trachea and bronchi. Thus it may increase the efficiency of the cough reflex and facilitate removal of the secretions; however, objective evidence for this is limited and conflicting. By increasing respiratory tract fluid, guaifenesin reduces the viscosity of tenacious secretions and acts as an expectorant. Guaifenesin, a commonly used agent for the treatment of cough, is termed an expectorant since it is believed to alleviate cough discomfort by increasing sputum volume and decreasing its viscosity, thereby promoting effective cough. Despite its common usage, relatively few studies, yielding contrasting results, have been performed to investigate the action and efficacy of guaifenesin. To evaluate the effect of guaifenesin on cough reflex sensitivity. Randomized, double-blind, placebo-controlled trial. Fourteen subjects with acute viral upper respiratory tract infection (URI) and 14 healthy volunteers. On 2 separate days, subjects underwent capsaicin cough challenge 1 to 2 hr after receiving a single, 400-mg dose (capsules) of guaifenesin or matched placebo. Measurements and results: The concentration of capsaicin inducing five or more coughs (C(5)) was determined. Among subjects with URI, mean (+/- SEM) log C(5) after guaifenesin and placebo were 0.92 +/- 0.17 and 0.66 +/- 0.14, respectively (p = 0.028). No effect on cough sensitivity was observed in healthy volunteers. /The/ results demonstrate that guaifenesin inhibits cough reflex sensitivity in subjects with URI, whose cough receptors are transiently hypersensitive, but not in healthy volunteers. Possible mechanisms include a central antitussive effect, or a peripheral effect by increased sputum volume serving as a barrier shielding cough receptors within the respiratory epithelium from the tussive stimulus.

Pharmacodynamics

Guaifenesin is categorized as an expectorant that acts by enhancing the output of phlegm (sputum) and bronchial secretions via decreasing the adhesiveness and surface tension of such material. Furthermore, guaifenesin elicits an increased flow of less viscous gastric secretions that subsequently promote ciliary action - all actions that ultimately change dry, unproductive coughing to coughs that are more productive and less frequent. Essentially, by decreasing the viscosity and adhesiveness of such secretions, guaifenesin enhances the efficacy of mucociliary activity in removing accumulated secretions from the upper and lower airway.